-
Product Insights
Summit & Sip/ TRG 425 Summit – 415-435 Summit Avenue Mixed-Use Building – New Jersey
Equip yourself with the essential tools needed to make informed and profitable decisions with our Summit & Sip/ TRG 425 Summit - 415-435 Summit Avenue Mixed-Use Building - New Jersey report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Company Profile
The Restaurant Group Plc – Company Profile
The Restaurant Group plc (TRG) is a casual dining restaurant and pub company. The company operates restaurants and pubs under various brands including Frankie & Benny’s,, Cost to Coast, Brunning & Price, Joe’s Kitchen, Garfunkel’s, Firejacks TRG concessions, Wagamama and Chiquito. TRG serves breakfast, lunch, evening snacks, dinner, and desserts and drinks. The company’s restaurants offer Italian, Mexican, British and American cuisines including pizzas, pastas, grills, sandwiches, steaks, sides, burgers and other popular dishes. It operates outlets in London, Bath,...
Add to Basket -
Company Profile
Aker ASA – Company Profile
Aker ASA (Aker), a subsidiary of TRG Holding AS, is an industrial investment company that operates through industrial holdings and financial investments. The company invests mainly in energy, fisheries and marine biotech, offshore oil and gas extraction, environment, renewable energy and green technologies. It focuses on technologies that reduce carbon dioxide emissions. Aker promotes operational improvements, sector structural rationalization, optimal financing, mergers, acquisitions, and sales of business. It also invests in specialized funds managed by various management companies. Aker is...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (lidocaine + oxybutynin) SR
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (lidocaine + oxybutynin) SR Drug Details TRG-100 is under development for the treatment of...
-
Product Insights
Muscarinic Acetylcholine Receptor M2 (CHRM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Muscarinic Acetylcholine Receptor M2 (CHRM2) is expressed in various regions of the brain including the cerebellum, cerebral cortex, hippocampus, medulla, striatum, thalamus, lungs, and prostate. An increase in M2 receptors has been associated with depression. The CHRM2 pipeline market research report provides comprehensive information on the CHRM2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its...